At the U.S. Transhumanist Party’s Virtual Enlightenment Salon on June 1, 2025, Unlimited Bio COO Vladimir Leshko unveiled the company’s ultra-fast, low-cost platform for aging interventions. In a 114-minute livestream, Leshko:
The presentation raised genuine interest and many questions from U.S. Transhumanist Party Chairman Gennady Stolyarov II, renowned Death of Death author José Luis Cordeiro and the Party memebers regarding the political climate in Prospera, the safety of gene therapies, leveraging the immune response after injections, costs, XPRIZE Healthspan participation, treating hair loss, Unlimited Bio’s seed-round plans, and other topics.
- Emphasized the need for combinatorial gene-therapy approaches to tackle multifactorial aging pathways.
- Showcased Unlimited Bio’s VEGF gene-therapy pilot, highlighting early safety and efficacy signals.
- Outlined the 2025 roadmap: adding Follistatin, αKlotho, BDNF, PGC-1α, and hTERT monotherapies, plus the inaugural VEGF + Follistatin + BDNF + αKlotho combination trial.
- Detailed the strategy of leveraging Special Economic Zones (e.g., Prospera ZEDE, Roatán, Honduras) to slash regulatory timelines and costs.
The presentation raised genuine interest and many questions from U.S. Transhumanist Party Chairman Gennady Stolyarov II, renowned Death of Death author José Luis Cordeiro and the Party memebers regarding the political climate in Prospera, the safety of gene therapies, leveraging the immune response after injections, costs, XPRIZE Healthspan participation, treating hair loss, Unlimited Bio’s seed-round plans, and other topics.